In an article published in Cell Stem Cell, Guido van Mierlo from the lab of Hendrik Marks, theme Cancer development and immune defense, together with collaborators, show how the cells of the embryo are getting prepared to form the various cell types that are present in an organism, such as skin cells or heart cells.Publication: link.
A couple of years ago the Marks lab showed that the genome undergoes a reset towards a blank slate which the enables the embryo to further develop towards an organism, in particular DNA methylation is widely being removed. We now show that this reset has an important effect on the proteins that packaging the genome (the histones). In particular, some modifications of the histones are actively removed from the histones, while other modifications are newly linked to the histones. For one of the histone modifications, this results in a complete rewiring of the genome.
Altogether, these modifications to the DNA and the histones result in compaction of the DNA during development, which is preparatory for further specialization of the cells.
Related news items
KWF Roadshow 11 November 201910 October 2019
In which way(s) can KWF provide optimal support to oncological research and care? How can we maximize impact on our investments? These questions are pivotal in Ambition 2030: the vision that KWF developed in close cooperation with stakeholders in the oncological field.read more
A personal touch of Frank Wagener10 October 2019
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Frank Wagener.read more
Dorine Swinkels collaborates with winners of the Nobel Prize in Physiology or Medicine9 October 2019
The Nobel Prize in Physiology or Medicine 2019 was awarded jointly to William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza for their discoveries of how cells sense and adapt to oxygen availability.read more
Scaling up nanotherapy7 October 2019
Scaling up and translating nanotherapy from pre-clinical work in small animal models to a clinical application is not trivial. Raphael Duivenvoorden, theme Renal disorders, and colleagues, published their results on translating a new nanoimmunotherapy in the journal Science Translational Medicine.read more